Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gout market across 7MM set to reach $10.8 bn in 2032 fueled by novel ULTs and rising prevalence:…
There are nine therapies in the late-stage pipeline, most of which are urate-lowering therapies (ULTs) entering the US and Japan…
J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment…
ADCs continue to be the hot topic in big pharma. Prior to the announced J&J deal, last year alone saw 155 deals struck for the…
Akumentis Healthcare launches Clasepi, synthetic CBD for epilepsy
Clasepi comes with important usage considerations; it is not recommended for individuals allergic to cannabidiol or any of its…
Lupin launches Varenicline Tablets in the US
It is indicated for use as an aid to smoking cessation treatment
Healthcare industry reported 84 deals worth $38.6 billion, in Dec 2023
Deal value increased by 4.4 per cent in Dec 2023, compared to Dec 2022
Supriya Lifescience gets GMP certification from ANVISA Brazil
ANVISA certification will help Supriya Lifescience to strategically grow its footprint in the Brazilian pharmaceutical sector and…
Hikal, Gujarat govt ink MoU at Vibrant Gujarat Summit
Under the terms of the MoU, Hikal invests Rs 500 crores into the existing fine chemical plant at Panoli, Gujarat
Biotech funding recovery is on the horizon in 2024: GlobalData
40 per cent of healthcare industry professionals surveyed globally expressed an optimistic or very optimistic sentiment on the …
UP govt to build a 1472-acre pharma park in Lalitpur, Bundelkhand
The identified villages for the survey include Saidpur (426 acres), Gadolikala (249 acres), Largan (239 acres), Karounda (116…
Lupin launches Second Edition of Aptivate Champion Run for Kids
It promotes children’s well-being through fitness and nutrition